CPAP治疗中残余呼吸暂停低通气指数变异性的相关因素
该注册研究纳入1126例接受CPAP远程监测至少90天的OSA患者,用隐马尔可夫模型分析残余呼吸暂停低通气指数(rAHI)的日间轨迹,识别出低、中、高变异三组,并发现年龄、诊断时OSA严重度、心衰、阿片类及酒精使用、精神行为障碍、TIA/卒中、口鼻面罩和漏气量等因素与高rAHI变异性相关。
要点
- rAHI变异性可分为低、中、高三组,高变异组占28%。
- 心衰、阿片类及酒精使用、精神行为障碍、TIA/卒中与高rAHI变异性相关。
- 口鼻面罩及CPAP漏气量较高也与高rAHI变异性相关。
核心结论
- 识别与高rAHI变异性相关的表型特征和因素,有助于早期干预并制定CPAP治疗的个体化随访路径。
研究设计与样本
- 注册研究,纳入1126例确诊OSA并接受CPAP治疗且远程监测至少90天的患者,采用隐马尔可夫模型分析rAHI日间轨迹,并用有序logistic回归识别相关因素。
主要发现
- 隐马尔可夫模型识别出三组rAHI轨迹:低变异组393例(35%)、中变异组420例(37%)、高变异组313例(28%)。
- 多因素分析显示,与高rAHI变异性相关的因素包括年龄、诊断时OSA严重度、心衰、阿片类药物和酒精消费、精神与行为障碍、短暂性脑缺血发作和卒中、口鼻面罩以及使用CPAP时的漏气水平。
- 纳入患者中位年龄66岁(IQR 57-73),男性791例(70.3%),中位BMI 30.6 kg/m2(IQR 26.8-35.2)。
临床怎么用
- 对存在心衰、精神行为障碍、TIA/卒中、使用阿片类或酒精、使用口鼻面罩或漏气量较高的CPAP患者,应警惕高rAHI变异性并加强随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: CPAP is the first-line therapy for OSA. A high or variable residual apnea-hypopnea index (rAHI) reflects treatment failure and potentially is triggered by exacerbation of cardiovascular comorbidities. Previous studies showed that high rAHI and large rAHI variability are associated with underlying comorbidities, OSA characteristics at diagnosis, and CPAP equipment, including mask type and settings. RESEARCH QUESTION: What factors are associated with predefined groups with low to high rAHI variability? STUDY DESIGN AND METHODS: This registry-based study included patients with a diagnosis of OSA who were receiving CPAP treatment with at least 90 days of CPAP remote monitoring. We applied the hidden Markov model to analyze the day-to-day trajectories of rAHI variability using telemonitoring data. An ordinal logistic regression analysis identified factors associated with a risk of having a higher and more variable rAHI with CPAP treatment. RESULTS: The 1,126 included patients were middle-aged (median age, 66 years; interquartile range [IQR], 57-73 years), predominantly male (n = 791 [70.3%]), and obese (median BMI, 30.6 kg/m2 (IQR, 26.8-35.2 kg/m2). Three distinct groups of rAHI trajectories were identified using hidden Markov modeling: low rAHI variability (n = 393 [35%]), moderate rAHI variability group (n = 420 [37%]), and high rAHI variability group (n = 313 [28%]). In multivariate analysis, factors associated with high rAHI variability were age, OSA severity at diagnosis, heart failure, opioids and alcohol consumption, mental and behavioral disorders, transient ischemic attack and stroke, an oronasal mask, and level of leaks when using CPAP. INTERPRETATION: Identifying phenotypic traits and factors associated with high rAHI variability will allow early intervention and the development of personalized follow-up pathways for CPAP treatment.
引用
- Rossetto A, Midelet A, Baillieul S, et al. Factors Associated With Residual Apnea-Hypopnea Index Variability During CPAP Treatment. Chest. 2023. PMID: 36642368. doi:10.1016/j.chest.2022.12.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。